KML-010 is a drug derived from spiperone. It functions as a highly selective 5-HT2A receptor antagonist with negligible affinity for the 5-HT1A or 5-HT2C receptors and over 400-fold lower affinity for the D2 receptor in comparison to spiperone.
This page contains content from the copyrighted Wikipedia article "KML-010"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.